The new patents contain claims to a pharmaceutical composition for pain relief containing a narcotic analgesic in micellar form.
Rose Perri, COO of Generex, said: “We are pleased that our patent portfolio is expanding to include the pain relief application. As we continue the pivotal Phase III studies of our flagship product, Generex Oral-lyn, we seek additional applications for our proprietary drug platform technology.”